E1-E4+ adenoviral gene transfer vectors function as a 'pro-life' signal to promote survival of primary human endothelial cells

Blood

Volumn 93, Issue 9, 1999, Pages 2936-2944

  Ramalingam, Ramachandran ^b   Rafii, Shahin ^b   Worgall, Stefan ^b   Brough, Douglas E ^b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN BAX; PROTEIN BCL 2; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; GENOME; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; UMBILICAL CORD; VASCULAR ENDOTHELIUM;

EID: 0033135405     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2936     Document Type: Article

References (63)

1. Risau W: Differentiation of endothelium. FASEB J 9:926, 1995
2. Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 87:1153, 1996
3. Beynon HLC, Neild GH, Pusey CD, Walport MJ: Vasculitis and endothelium, in: The Endothelium: An Introduction to Current Research. New York, NY, Wiley-Liss, Inc, 1990, p 209
4. Brady AJB, Warren JB: Endothelial damage during angioplasty, in: The Endothelium: An Introduction to Current Research. New York, NY, Wiley-Liss, Inc, 1990, p 157
5. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46:467, 1986
6. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745, 1973
7. Gimbrone Jr MA, Cotran RS, Folkman J: Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60:673, 1974
8. Gospodarowicz D, Moran J, Braun D, Birdwell C: Clonal growth of bovine vascular endothelial cells: Fibroblast growth factor as a survival agent. Proc Natl Acad Sci USA 73:4120, 1976
9. Hansson GK, Schwartz SM: Evidence for cell death in the vascular endothelium in vivo and in vitro. Am J Pathol 112:278, 1983
10. Brindle NP: Growth factors in endothelial regeneration. Cardiovasc Res 27:1162, 1993
11. Schwartz SM, Gajdusek CM: Contact inhibition in the endothelium, in Jaffe EA (ed): Biology of Endothelial Cells. Boston, MA, Martinus Nijhoff Publishers, 1984, p 66
12. Hase M, Araki S, Kaji K, Hayashi H: Classification of signals for blocking apoptosis in vascular endothelial cells. J Biochem (Tokyo) 116:905, 1994
13. Araki S, Shimada Y, Kaji K, Hayashi H: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 168:1194, 1990
14. FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med 187:579, 1998
15. Hersh J, Crystal RG, Bewig B: Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther 2:124, 1995
16. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N: A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70:4646, 1996
17. Frey BM, Rafii S, Teterson M, Eaton D, Crystal RG, Moore MAS: Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: Insights into the pathophysiology of osteomyelofibrosis. J Immunol 160:691, 1998
18. Brough DE, Lizonova A, Hsu C, Kulesa VA, Kovesdi I: A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol 70:6497, 1996
19. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet LD, Perricaudt M, Guggino WB, Pavirani A, Lecocq JP, Crystal RG: In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143, 1992
20. Graham FL, Prevec L: Manipulation of adenovirus vectors, in Murray EJ (ed): Methods in Molecular Biology, Vol 7: Gene Transfer and Expression Protocols. Clifton, NJ, The Humana Press, Inc, 1991, p 109
21. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 8:42, 1994
22. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
23. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
24. McDonnell TJ, Deane N, Plan FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989
25. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
26. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the Bcl2 family and cell death. Blood 88:386, 1996
27. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609, 1993
28. Nevins JR: Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell 26:213, 1981
29. Armentano D, Zabner J, Sacks C, Sookdeo CC, Smith MP, St.George JA, Wadsworth SC, Smith AE, Gregory RJ: Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J Virol 71:2408, 1997
30. Gao GP, Yang Y, Wilson JM: Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol 70:8934, 1996
31. Kaplan JM, Armentano D, Sparer TE, Wynn SG, Peterson PA, Wadsworth SC, Couture KK, Pennington SE, St.George JA, Gooding LR, Smith AE: Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum Gene Ther 8:45, 1997
32. Huang MM, Hearing P: The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. Genes Dev 3:1699, 1989
33. Dobner T, Horikoshi N, Rubenwolf S, Shenk T: Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470, 1996
34. Shenk T: Adenoviridae: The viruses and their replication, in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, PA, Lippincott-Raven Publishers, 1996, p 2111
35. Kondo S, Yin D, Aoki T, Takahashi JA, Morimura T, Takeuchi J: bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp Cell Res 213:428, 1994
36. Quinlan MP: E1A 12S in the absence of E1B or other cooperating oncogenes enables cells to overcome apoptosis. Oncogene 8:3289, 1993
37. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E: The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89:7742, 1992
38. L and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14:405, 1997
39. Van Der Vliet PC, Levine AJ, Ensinger MJ, Ginsberg HS: Thermolabile DNA binding proteins from cells infected with a temperature-sensitive mutant of adenovirus defective in viral DNA synthesis. J Virol 15:348, 1975
40. Chen P, Tian J, Kovesdi I, Bruder JT: Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits fas ligand-induced apoptosis. J Biol Chem 273:5815, 1998
41. Ilan Y, Droguett G, Chowdhury NR, Li Y, Sengupta K, Thummala NR, Davidson A, Chowdhury JR, Horwitz MS: Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci USA 94:2587, 1997
42. Wold WS, Gooding LR: Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1, 1991
43. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukayama M, Stier LE, Paakko PK, Gilardi P, Stratford-Perricaudet LD, Perricaudet M, et al: Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431, 1991
44. Bridge E, Ketner G: Redundant control of adenovirus late gene expression by early region 4. J Virol 63:631, 1989
45. Hardy S, Engel DA, Shenk T: An adenovirus early region 4 gene product is required for induction of the infection-specific form of cellular E2F activity. Genes Dev 3:1062, 1989
46. Ketner G, Bridge E, Virtanen A, Hemstrom C, Pettersson U: Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids. Nucleic Acids Res 17:3037, 1989
47. Sandler AB, Ketner G: Adenovirus early region 4 is essential for normal stability of late nuclear RNAs. J Virol 63:624, 1989
48. Javier R, Raska Jr K, Shenk T: Requirement for the adenovirus type 9 E4 region in production of mammary tumors. Science 257:1267, 1992
49. Muller U, Kleinberger T, Shenk T: Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1. J Virol 66:5867, 1992
50. Kleinberger T, Shenk T: Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junb transcription. J Virol 67:7556, 1993
51. Weiss RS, McArthur MJ, Javier RT: Human adenovirus type 9 E4 open reading frame 1 encodes a cytoplasmic transforming protein capable of increasing the oncogenicity of CREF cells. J Virol 70:862, 1996
52. Berk AJ, Lee F, Harrison T, Williams J, Sharp PA: Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger mas. Cell 17:935, 1979
53. Jones N, Shenk T: An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci USA 76:3665, 1979
54. Nevins JR: Regulation of early adenovirus gene expression. Microbiol Rev 51:419, 1987
55. Brough DE, Hsu C, Kulesa VA, Lee GM, Cantolupo LJ, Lizonova A, Kovesdi I: Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J Virol 71:9206, 1997
56. Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T: The adenovirus E4orf6 protein can promote E1a/E1b-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci USA 94:1206, 1997
57. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
58. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D: Immediate early up-regulation of bax expression by p53 but not tgf beta 1: A paradigm for distinct apoptotic pathways. Oncogene 9:1791, 1994
59. Bruder JT, Kovesdi I: Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 71:398, 1997
60. McElvaney NG, Crystal RG: IL-6 release and airway administration of human CFTR cDNA adenovirus vector. Nature Med 1:182, 1995
61. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, de Martin R: Inhibition of endothelial cell activation by adenovirus-mediated expression of IkBbα, an inhibitor of the transcription factor NF-kappaB. J Exp Med 183:1013, 1996
62. Amin R, Wilmott R, Schwarz Y, Trapnell B, Stark J: Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro. Hum Gene Ther 6:145, 1995
63. Moore M, Horikoshi N, Shenk T: Oncogenic potential of the adenovirus E4orf6 protein. Proc Natl Acad Sci USA 93:11295, 1996